Perhaps our definitions of a failed trial differ.
Post# of 148170
CD10 met multiple endpoints (phase 2 trials are to identify primary endpoints in phase 3)
CD12 missed primary end point, but taught us (hopefully) how to better design a trial for success.
What other trials have we failed? Ill wait.